WFH statement: inclusion of cryoprecipitate in the WHO’s EML and EMLc
The World Federation of Hemophilia (WFH) is deeply concerned by the inclusion of pathogen-reduced and non-pathogen reduced cryoprecipitate in the World Health Organization’s 23rd Essential Medicines List (EML) and Essential Medicines List for Children (EMLc).